Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one

Vaccine
Julia L HurwitzC Coleclough

Abstract

Human parainfluenza virus-type I (hPIV-1) infections are a common cause of "group" and hospitalizations among young children. Here we address the possibility of using the xenotropic Sendai virus [a mouse parainfluenza virus (PIV)] as a vaccine for hPIV-1. Sendai virus was administered to six African green monkeys (Cercopithecus aethiops) by the intranasal (i.n.) route. A long lasting virus-specific antibody response was elicited, both in the serum and nasal cavity. Sendai virus caused no apparent clinical symptoms in the primates, but live virus was detected in the nasal cavity for several days after inoculation. No virus was detected after a second dose of Sendai virus was administered on day 126 after the initial priming. Animals were challenged with hPIV-1 i.n. on day 154. All six vaccinated animals were fully protected from infection while six of six control animals were infected with hPIV-1. The antibody responses induced by Sendai virus immunizations proved to be greater than those induced by hPIV-1. These results demonstrate that unmanipulated Sendai virus is an effective vaccine against hPIV-1 in a primate model and may constitute a practical vaccine for human use.

Citations

Oct 30, 2003·Viral Immunology·Adrian W Zuercher
Jul 23, 2005·Viral Immunology·Toru TakimotoKaren S Slobod
Apr 15, 2003·Clinical Microbiology Reviews·Kelly J Henrickson
Oct 15, 2008·Infection and Immunity·Cynthia A RossiElizabeth K Leffel
Oct 17, 2006·Journal of Virology·Alexander BukreyevPeter L Collins
Dec 10, 2015·Expert Review of Vaccines·Charles J Russell, Julia L Hurwitz
Dec 17, 2008·Virus Research·Olivier TouzeletUltan F Power
Jun 9, 2006·Research in Veterinary Science·P Faísca, D Desmecht
Oct 13, 2011·Expert Review of Vaccines·Julia L Hurwitz
May 25, 2002·The Journal of General Virology·Munehide KanoYoshiyuki Nagai
Aug 24, 2013·Expert Review of Respiratory Medicine·Patricia A JorqueraRalph A Tripp
Jan 13, 2018·Viral Immunology·Charles J RussellJulia L Hurwitz
Jun 29, 2007·Gene Therapy·S FerrariE W F W Alton
Nov 11, 2014·Expert Review of Vaccines·Mark A Mogler, Kurt I Kamrud
May 10, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·I MasakiK Sueishi
Jun 22, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sherri L SurmanJulia L Hurwitz
Feb 26, 2020·Pathogens·Daniela Ogonczyk MakowskaGuy Boivin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.